Atosiban clinical trials
Also written Tractocile.
How each study uses atosiban is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the atosiban studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- 20 Jan 2000 · Tractocile · EMEA/H/C/000253 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
17 studies that test it; most in 2025 (3)
| Year | Studies |
|---|---|
| 2007 | 2 |
| 2008 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2025 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 16
University of Electronic Science and Technology of China (2) · Children's Hospital of Chongqing Medical University (1) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · AZ Jan Palfijn Gent (1) · Polish Mother Memorial Hospital Research Institute (1) · Ferring Pharmaceuticals (1) · The University of Hong Kong (1) · Raed Salim (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Tocolytic Agents source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test atosiban.
- Jun 2027Atosiban in Women With Previous Implantation Failure and Abnormal Uterine ContractionsNot applicable · Northwest Women's and Children's Hospital, Xi'an, Shaanxi
Studies
Open first, then newest update. How each study uses atosiban is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 17
- Atosiban in Women With Previous Implantation Failure and Abnormal Uterine ContractionsRecruitingNot applicableNorthwest Women's and Children's Hospital, Xi'an, ShaanxiNCT07185230Written as AtosibanHow we know
- The Effect of Oral Oxytocin and Atosiban on Top-down Attention ( OTAtosiban )RecruitingEarly Phase 1University of Electronic Science and Technology of ChinaNCT07140237Written as AtosibanHow we know
- The Effect of Oral Oxytocin and Atosiban on Social AttentionRecruitingEarly Phase 1University of Electronic Science and Technology of ChinaNCT07093060Written as AtosibanHow we know
- Perioperative Use of Atosiban for Ultrasound-indicated Cerclage to Reduce Spontaneous Preterm Birth(sPTB)CompletedNot applicableChildren's Hospital of Chongqing Medical UniversityNCT06537778Written as AtosibanHow we know
- Atosiban Versus Placebo in the Treatment of Late Threatened Pre-term BirthCompletedPhase 4Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)NCT05693688Written as AtosibanHow we know
- The Effect of Selective Oxytocin Receptor Inhibitors on Endometriosis-related PainStatus unknownPhase 2Radboud University Medical CenterNCT05382143Written as AtosibanHow we know
- Oxytocin Antagonist in Patients With Repeated Failure of ImplantationCompletedPhase 4AZ Jan Palfijn GentNCT01673399Written as AtosibanHow we know
- Effect of Oxytocin Antagonists on Implantation Success Rates of Frozen-thawed Embryo TransferStatus unknownNot applicableBezmialem Vakif UniversityNCT03904745Written as AtosibanHow we know
- Oxidative Stress in Women Treated With Atosiban for Impending Preterm BirthCompletedNot applicablePolish Mother Memorial Hospital Research InstituteNCT03570294Written as AtosibanHow we know
- Effect of Oxytocin and Vasopressin Antagonists on Uterine ContractionsCompletedPhase 2Ferring PharmaceuticalsNCT00587327Written as AtosibanHow we know
- A Randomized Double Blind Comparison of Atosiban in Patients With RIF Undergoing IVF TreatmentStatus unknownPhase 1Shanghai First Maternity and Infant HospitalNCT02893722Written as atosibanHow we know
- Tocolytic Therapy for Preterm Labor in Multiple GestationStatus unknownPhase 3Tel-Aviv Sourasky Medical CenterNCT02725736Written as AtosibanHow we know
- Use of Atosiban in in Vitro Fertilization (IVF) TreatmentCompletedPhase 4The University of Hong KongNCT01501214Written as AtosibanHow we know
- Nifedipine Compared to Atosiban for Treating Preterm LaborCompletedPhase 4Raed SalimNCT00599898Written as AtosibanHow we know
- Atosiban Improves Implantation and Pregnancy Rates in Patients With Repeated Implantation FailureCompletedNot applicableAn Sinh HospitalNCT01493440Written as atosibanHow we know
- Single Versus Combination Therapy in Acute TocolysisCompletedPhase 2Tawam HospitalNCT01429545Written as AtosibanHow we know
- Influence of Tocolytical Medications on Hemodynamics (Central and Peripheral) and Vascular Function in a Pilot Study to Determine the Design of the Final Study and the Final Study ItselfCompletedPhase 1University Hospital, GhentNCT00679705Written as AtosibanHow we know
Given beside what is tested · 1 — atosiban is usual care or a partner of the new treatment
As the comparator · 3 — what is tested is compared with atosiban
- A Randomized Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban for Women in Spontaneous Preterm LabourTerminatedPhase 3GlaxoSmithKlineNCT02292771Written as AtosibanHow we know
- Follow up Study to Assess Long Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment StudiesCompletedPhase 3GlaxoSmithKlineNCT02292784Written as AtosibanHow we know
- Nifedipine Treatment in Preterm LaborWithdrawnPhase 3Hospital Clinico Universitario de SantiagoNCT01314859Written as AtosibanHow we know
Codes
What other systems call atosiban · ClinicalTrials.gg INT003241
- MeSH (NLM) C047046atosibanConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 081D12SI0ZATOSIBANConfirmed FDA, NLM, Wikidata
- RxNorm 59639Confirmed FDA, Wikidata
- Wikidata Q421322atosibanConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C84815AtosibanOne source FDA
- DrugBank DB09059One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C047046 | atosiban | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 081D12SI0Z | ATOSIBAN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 59639 | — | Confirmed FDA, Wikidata |
| Wikidata | Q421322 | atosiban | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C84815 | Atosiban | One source FDA |
| DrugBank | DB09059 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.